Publication:
25OH VITAMIN D LEVELS IN REFERENCE HOSPITAL LABORATORIES FROM TURKEY: A MULTICENTER NATIONWIDE STUDY

dc.contributor.authorsYavuz, D. Gogas; Ersoy, R.; Bilen, H.; Canturk, Z.; Altuntas, Y.; Turvida, S. G.
dc.date.accessioned2022-03-12T16:24:26Z
dc.date.available2022-03-12T16:24:26Z
dc.date.issued2019
dc.identifier.doidoiWOS:000475685503054
dc.identifier.eissn1433-2965
dc.identifier.issn0937-941X
dc.identifier.urihttps://hdl.handle.net/11424/226341
dc.identifier.wosWOS:000475685503054
dc.language.isoeng
dc.publisherSPRINGER LONDON LTD
dc.relation.ispartofOSTEOPOROSIS INTERNATIONAL
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.title25OH VITAMIN D LEVELS IN REFERENCE HOSPITAL LABORATORIES FROM TURKEY: A MULTICENTER NATIONWIDE STUDY
dc.typeconferenceObject
dspace.entity.typePublication
local.avesis.id96450b6c-e7aa-40d5-ad64-c2a0a83fed25
local.conference.dateAPR 04-07, 2019
local.conference.locationParis, FRANCE
local.conference.sponsorInt Osteoporosis Fdn, ESCEO, Mylan, UCB, IBSA, Medimaps, Lilly, Hologic, Strax Corp, Kyowa Kirin, Galgo Med, EffRx, Amgen, Abiogen Pharma, Medi, Fidia Pharma Grp, TRB Chemedica Sa, AgNovos Healthcare GmbH, Expanscience Labs, Wisepress Com, GE, Pierre Fabre, Roche, Echolight, Thuasne, Theramex, Bindex, Gedeon Richter, Sinklar Conf Management B V
local.conference.titleWorld Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO)
local.import.packageSS15
local.indexed.atWOS
local.journal.numberofpages1
local.journal.quartileQ2
oaire.citation.endPageS569
oaire.citation.startPageS569
oaire.citation.titleOSTEOPOROSIS INTERNATIONAL
oaire.citation.volume30

Files

Collections